Stephen Berenson Moderna, Inc. (MRNA) insider trading activity

Stephen Berenson is Director of Moderna, Inc.. Currently has a direct ownership of 22,203 shares of MRNA, which is worth approximately $1.92 Million. The most recent transaction as insider was on May 03, 2024, when has been sold 732 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.2K

0% 3M change

3.41% 12M change

Total Value Held $1.92 Million

Stephen Berenson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 03 2024	BUY Exercise of conversion of derivative security	-	732 Added 3.19%	22,203 Common Stock
Apr 28 2023	BUY Exercise of conversion of derivative security	-	670 Added 3.03%	21,471 Common Stock
Apr 28 2022	BUY Exercise of conversion of derivative security	-	703 Added 3.27%	20,801 Common Stock
Aug 19 2021	SELL Bona fide gift	-	2,700 Reduced 11.84%	20,098 Common Stock
Dec 11 2018	BUY Conversion of derivative security	-	22,798 Added 50.0%	22,798 Common Stock

Also insider at

MCRB

Seres Therapeutics, Inc. Healthcare